Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion type Assertion NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_head.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion wasGeneratedBy ECO_0000203 NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_provenance.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion wasDerivedFrom befree-20140225 NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_provenance.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion SIO_000772 24011934 NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_provenance.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion evidence source_evidence_literature NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_provenance.
- NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_assertion description "[Dysregulation of the phosphoinositide 3-kinase/mammalian target of rapamycin (PI3K/mTOR) and RAS/extracellular signal-regulated kinase (ERK) pathways is common in ovarian cancer, providing potential new targets for 2nd line therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586939.RAtTEJ3yqY770rtRb3lQPouaMtZFDJHjH3bTTR_GZAOkg130_provenance.